Neuron23
Neuron23 is developing a precision medicine approach designed to improve the lives of people with Parkinson’s disease.
$97M Series B+ ·
Source: startupintros.com
Total raised: $197M across 2 sourced rounds
All 2 rounds ↓Signals
Neuron23 | 472 days from X account to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $97M | — | startupintros.com | |
| Series B+ | $100M | fundraisingfox.com |
Timeline
- X account created
- Website created
Founders and team
AK
Adam Knight FounderAY
Andrew Yost Chief Business OfficerMV
Marcel van der Brug VP Genetics and Data SciencesNS
Nancy Stagliano Chief Executive OfficeSJ
Sam Jackson Chief Medical Officer
Investors
AAcorn Bioventures
BBlue Owl Capital
CCowen Healthcare Investments
HHBM Healthcare Investments
HHBM PartnersKKleiner Perkins
MMichael J. Fox Foundation
PPerceptive Advisors
RRedmile Group
SSoftBank Vision Fundlead investor
SSurveyor Capital
WWestlake Village BioPartners
Companies like Neuron23
AArboretum$30M Series A · Oct 2026
LLifeMine Therapeutics$75M Series B+ · Aug 2026
DDelphia Therapeutics$67M Series A · May 2024
HHotSpot Therapeutics$100M Series B+ · Nov 2021
SSeragy$13.43M · Oct 2026
MMatchpoint Therapeutics$150M Series B+ · Oct 2026
Other companies backed by SoftBank Vision Fund
LLabelbox$100M Series B+ · Oct 2026
CCMR Surgical$400M Series B+ · Oct 2026
OOPay$185M Series B+ · Oct 2026
ZZenity$125M Series B+ · Oct 2026
EEmergent$130M Series B+ · Jul 2026
WWHOOP$575M Series B+ · Jun 2026
SoftBank Vision Fund portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/neuron23 (get a free API key).